Published in JAMA on January 26, 2005
Mapping Novel Disease Genes for Dilated Cardiomyopathy | NCT00046618
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Inherited disorders of voltage-gated sodium channels. J Clin Invest (2005) 3.29
Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation (2008) 2.56
Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol (2009) 2.53
Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest (2011) 2.38
Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci (2008) 2.17
A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther (2007) 2.17
Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med (2008) 2.14
Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol (2013) 2.09
Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol (2011) 2.02
Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. Heart Rhythm (2008) 2.01
Long QT syndrome-associated mutations in intrauterine fetal death. JAMA (2013) 2.00
Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae. Heart Rhythm (2009) 1.91
Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med (2010) 1.90
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm (2011) 1.85
Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circ Cardiovasc Genet (2012) 1.78
Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation. J Am Coll Cardiol (2008) 1.77
The genetics of dilated cardiomyopathy. Curr Opin Cardiol (2010) 1.76
X-linked nonsyndromic sinus node dysfunction and atrial fibrillation caused by emerin mutation. J Cardiovasc Electrophysiol (2008) 1.68
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation (2012) 1.65
Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet (2006) 1.63
Molecular bases for the asynchronous activation of sodium and potassium channels required for nerve impulse generation. Neuron (2013) 1.56
Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy. Heart Rhythm (2014) 1.55
Genetics of cardiac arrhythmias. Heart (2005) 1.50
Unique mixed phenotype and unexpected functional effect revealed by novel compound heterozygosity mutations involving SCN5A. Heart Rhythm (2009) 1.50
Cardiac sodium channelopathies. Pflugers Arch (2009) 1.44
Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel. PLoS One (2015) 1.38
Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation (2011) 1.38
Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37
Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. Nat Med (2009) 1.36
Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet (2009) 1.25
Multiple loss-of-function mechanisms contribute to SCN5A-related familial sick sinus syndrome. PLoS One (2010) 1.25
Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects. Circ Res (2008) 1.16
The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet (2009) 1.15
Genetics of inherited cardiomyopathy. Eur Heart J (2011) 1.11
The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. Genet Med (2014) 1.10
Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum Genet (2010) 1.09
Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation. Cardiovasc Res (2011) 1.08
SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. Clin Transl Sci (2010) 1.07
A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype. PLoS One (2012) 1.07
Atrial fibrillation in congestive heart failure. Heart Fail Clin (2010) 1.07
Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. J Physiol (2013) 1.02
Inherited cardiac arrhythmias: diagnosis, treatment, and prevention. Dtsch Arztebl Int (2011) 1.01
Genetics of atrial fibrillation: implications for future research directions and personalized medicine. Circ Arrhythm Electrophysiol (2010) 1.01
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vasc Health Risk Manag (2011) 0.99
Ion channel mutations in AF: signal or noise? Heart Rhythm (2008) 0.99
Scn3b knockout mice exhibit abnormal sino-atrial and cardiac conduction properties. Acta Physiol (Oxf) (2009) 0.98
Genetics of atrial fibrillation: from families to genomes. J Hum Genet (2015) 0.96
Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res (2010) 0.94
Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies. Front Pharmacol (2012) 0.94
Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome. Pacing Clin Electrophysiol (2009) 0.94
Channelopathies from mutations in the cardiac sodium channel protein complex. J Mol Cell Cardiol (2013) 0.93
Common variants for atrial fibrillation: results from genome-wide association studies. Hum Genet (2011) 0.92
Atrial fibrillation: the role of common and rare genetic variants. Eur J Hum Genet (2013) 0.92
Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension. J Interferon Cytokine Res (2012) 0.92
Genetic origins of pediatric heart disease. Pediatr Cardiol (2009) 0.92
Atrial fibrillation and Brugada syndrome. J Am Coll Cardiol (2008) 0.89
LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice. Int J Cardiol (2009) 0.89
TNNI3K mutation in familial syndrome of conduction system disease, atrial tachyarrhythmia and dilated cardiomyopathy. Hum Mol Genet (2014) 0.89
Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence? Cardiol Res Pract (2011) 0.88
Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management. J Am Coll Cardiol (2015) 0.88
Biophysics, pathophysiology, and pharmacology of ion channel gating pores. Front Pharmacol (2014) 0.87
Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart. PLoS One (2011) 0.87
Pro-arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation - insights from modelling. J Physiol (2012) 0.86
A novel mutation in LAMIN A/C is associated with isolated early-onset atrial fibrillation and progressive atrioventricular block followed by cardiomyopathy and sudden cardiac death. Heart Rhythm (2009) 0.86
Mice deleted for heart-type cytochrome c oxidase subunit 7a1 develop dilated cardiomyopathy. Mitochondrion (2011) 0.86
Alternative splicing of the cardiac sodium channel creates multiple variants of mutant T1620K channels. PLoS One (2011) 0.85
Cell membrane expression of cardiac sodium channel Na(v)1.5 is modulated by alpha-actinin-2 interaction. Biochemistry (2010) 0.85
Significant Association Between CAV1 Variant rs3807989 on 7p31 and Atrial Fibrillation in a Chinese Han Population. J Am Heart Assoc (2015) 0.85
Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all. Expert Rev Mol Diagn (2010) 0.85
SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility. PLoS One (2012) 0.85
Mouse Models of SCN5A-Related Cardiac Arrhythmias. Front Physiol (2012) 0.85
Brugada syndrome. Orphanet J Rare Dis (2006) 0.84
New advances in the genetic basis of atrial fibrillation. J Cardiovasc Electrophysiol (2012) 0.84
Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy. Circ Cardiovasc Genet (2014) 0.82
Comprehensive mutation scanning of LMNA in 268 patients with lone atrial fibrillation. Am J Cardiol (2009) 0.82
GENETIC CAUSES OF DILATED CARDIOMYOPATHY. Prog Pediatr Cardiol (2014) 0.82
Induction of high STAT1 expression in transgenic mice with LQTS and heart failure. Biochem Biophys Res Commun (2007) 0.81
Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system. Front Physiol (2012) 0.81
Nav 1.5 mutations linked to dilated cardiomyopathy phenotypes: Is the gating pore current the missing link? Channels (Austin) (2013) 0.81
Dilated cardiomyopathy. Circ Arrhythm Electrophysiol (2012) 0.81
Conduction reserve and arrhythmias. Neth Heart J (2006) 0.80
Lone AF - etiologic factors and genetic insights into pathophysiolgy. J Atr Fibrillation (2010) 0.80
Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways. Glob Cardiol Sci Pract (2014) 0.80
Deletion of FoxO1 leads to shortening of QRS by increasing Na(+) channel activity through enhanced expression of both cardiac NaV1.5 and β3 subunit. J Mol Cell Cardiol (2014) 0.79
Molecular genetics of atrial fibrillation. Genome Med (2009) 0.79
Analysis on differential gene expression data for prediction of new biological features in permanent atrial fibrillation. PLoS One (2013) 0.79
Cellular hyper-excitability caused by mutations that alter the activation process of voltage-gated sodium channels. Front Physiol (2015) 0.78
Examining rare and low-frequency genetic variants previously associated with lone or familial forms of atrial fibrillation in an electronic medical record system: a cautionary note. Circ Cardiovasc Genet (2014) 0.78
Familial dilated cardiomyopathy: Current challenges and future directions. Glob Cardiol Sci Pract (2012) 0.78
SCN5A--a mechanistic link between inherited cardiomyopathies and a predisposition to arrhythmias? JAMA (2005) 0.77
Genetics of atrial fibrillation and possible implications for ischemic stroke. Stroke Res Treat (2011) 0.77
The genetic basis for inherited forms of sinoatrial dysfunction and atrioventricular node dysfunction. J Interv Card Electrophysiol (2015) 0.77
Wnt signalling suppresses voltage-dependent Na⁺ channel expression in postnatal rat cardiomyocytes. J Physiol (2015) 0.77
Atrial Fibrillation and SCN5A Variants. Card Electrophysiol Clin (2014) 0.76
Mutations in the Voltage Sensors of Domains I and II of Nav1.5 that are Associated with Arrhythmias and Dilated Cardiomyopathy Generate Gating Pore Currents. Front Pharmacol (2015) 0.76
Cytoskeletal basis of ion channel function in cardiac muscle. Future Cardiol (2006) 0.76
Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice. Arrhythm Electrophysiol Rev (2014) 0.76
A1180V of cardiac sodium channel gene (SCN5A): is it a risk factor for dilated cardiomyopathy or just a common variant in Han Chinese? Dis Markers (2013) 0.76
Personalized medicine and atrial fibrillation: will it ever happen? BMC Med (2012) 0.76
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med (1999) 5.61
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science (2002) 4.40
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science (2003) 3.71
Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A (2002) 3.59
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22
Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol (1992) 3.03
Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest (2003) 3.00
Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94
ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet (2004) 2.85
Cardiac conduction defects associate with mutations in SCN5A. Nat Genet (1999) 2.73
The failing heart. Nature (2002) 2.66
Intracellular Na+ regulation in cardiac myocytes. Cardiovasc Res (2003) 2.65
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol (2003) 2.47
X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation (1993) 2.30
A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res (2003) 2.15
Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol (1998) 2.03
Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation (2002) 1.95
Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol (2001) 1.92
Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest (2002) 1.84
Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res (2003) 1.82
Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation (2002) 1.65
Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest (1996) 1.52
Genetic control of sodium channel function. Cardiovasc Res (2003) 1.48
Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet (2001) 1.27
A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett (2000) 1.25
SNP S1103Y in the cardiac sodium channel gene SCN5A is associated with cardiac arrhythmias and sudden death in a white family. J Med Genet (2002) 1.13
Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations. Eur J Hum Genet (1994) 1.12
Inherited sodium channelopathies: a continuum of channel dysfunction. Trends Cardiovasc Med (2004) 1.07
Familial automaticity-conduction disorder with associated cardiomyopathy. West J Med (1986) 1.00
Frequency of development of idiopathic dilated cardiomyopathy among relatives of patients with idiopathic dilated cardiomyopathy. Am J Cardiol (2003) 0.98
Sodium and the heart: a hidden key factor in cardiac regulation. Cardiovasc Res (2003) 0.93
Na+ channel activators as positive inotropic agents for the treatment of chronic heart failure. Cardiovasc Drugs Ther (2001) 0.88
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol (2004) 8.97
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA (2010) 6.29
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation (2007) 3.78
Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation (2006) 3.76
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol (2002) 3.68
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59
Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation (2005) 3.34
Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet (2006) 3.15
Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol (2005) 3.13
Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol (2003) 3.09
Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet (2003) 3.01
Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA (2011) 2.86
ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet (2004) 2.85
A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci U S A (2006) 2.72
Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc (2005) 2.71
Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation (2009) 2.70
Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol (2005) 2.69
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2011) 2.69
Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol (2003) 2.62
Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol (2009) 2.53
Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease. Circ Cardiovasc Genet (2008) 2.50
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol (2008) 2.46
Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol (2005) 2.44
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation (2007) 2.43
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 2.40
Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc (2006) 2.37
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol (2009) 2.34
De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet (2012) 2.34
Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail (2012) 2.26
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2011) 2.24